Eikonoklastes Therapeutics is an early stage biopharmaceutical company that is dedicated to developing disruptive treatments for neurodegenerative diseases. Their main goal is to rapidly advance innovative medicines for areas of significant unmet medical need. They have acquired their first two assets, including a gene therapy for neurodegenerative diseases and a new generation of tissue factor th...